SHC1 and non-small cell lung carcinoma: Given the NSCLC is a heterogeneous disorder which consists of distinct molecular subtypes, more sophisticated methods will be needed to explore the application value of SHC1 expression and methylation in early diagnosis and prognosis of LUAD and LUSC patients.